Spinal Surgery With or Without Nerve Graft After Sudden Spinal Cord Injury
Tests adding nerve grafts to surgery for spinal cord injury.
Key facts
- Who runs it
- Francis Farhadi
- Where
- Lexington, United StatesSee the site
- Trial code
- Registry title
- Spinal Decompression Plus Nerve Graft Implantation Following TSCI
- Status
- Recruiting
- People taking part
- 10 people, planned
- Started
- 19 Apr 2024
- Expected to end
- 31 Dec 2026
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- DMED
- ANGI
- Record updated
- 10 December 2025
Who can take part
The trial is looking for adults with a recent, severe injury to the spinal cord in the neck or upper/mid back. They must be able to have spine surgery from the back within 48 hours of the injury.
- Age
- 18 to 80 years
- Sex
- All sexes
- Disease stage
- Acute traumatic spinal cord injury, not caused by a penetrating wound, at level C2 to C8 or T1 to T12. On admission the injury must be ASIA Impairment Scale grade A or B (complete or near-complete loss of function).
- Earlier treatment
- Cannot be taking part in another non-observational spinal cord injury study or receiving another investigational drug.
- Main reasons for not taking part
- ASIA Impairment Scale grade C, D or E
- Unconscious or unable to have a nerve check within the first 48 hours
- Other life-threatening injury, sepsis, or a condition likely to cause death within 12 months
- Surgery can be done safely from the front only
- Pregnancy, being a prisoner, or recent regular drug or alcohol abuse
Show the full registry criteria (18)Hide the full registry criteria
Who can take part
- Age: = 18 years and = 80 years
- Written informed consent by patient or legal authorized representative
- No other life-threatening injury
- No evidence of sepsis
- Acute cervical or thoracic SCI with ASIA Impairment Scale grade A or B on admission
- Non-penetrating SCI at neurologic level from C2 to C8 or T1 to T12
- The ability to undergo surgical intervention including study procedures through a posterior approach within 48 hours of injury
Who cannot take part
- Currently involved in another non-observational SCI research study or receiving another investigational drug
- Unconsciousness or other mental impairment that prevents neurological assessment within the first 48 hours
- Acute SCI with ASIA Impairment Scale grade C, D or E
- Other illness (including mental disorder) that could preclude accurate medical and neurological evaluation (at discretion of the principal investigator)
- A recent history of regular substance abuse (illicit drugs, alcohol), which in the opinion of the investigator would interfere with the subject's participation in the study
- Any condition likely to result in the patient's death within the next 12 months
- Spinal cord decompression and spinal stabilization can be safely performed through an anterior-only approach (i.e. posterior approach is not required)
- Unable to commit to the follow-up schedule
- Prisoner
- Subjects who in the opinion of the investigator are not suitable for inclusion in the study (reason to be documented)
- Pregnancy
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- Spinal cord injuries or acute traumatic spinal cord injury
This trial is currently available in United States.
- University of Kentucky Chandler Medical CenterLexington, United StatesContact: Francis Farhadi, MD, PhDTaking people
About the trial
What the trial wants to find out
This is a single-blinded (with outcome assessors blinded to treatment allocation), 12-month pilot study to evaluate of the safety, feasibility, and preliminary efficacy of dorsal myelotomy and expansive duraplasty performed either without or with autologous nerve graft implantation after acute traumatic spinal cord injury.
Read full original descriptionShow less
Ten participants will be allocated to receive either DMED (n=5) or DMED + ANGI (n=5) based on a block design. Participants and assessors will be blinded to group allocation. Excess sural nerve samples will be collected for banking/analysis (may include proteomic, culturing, genomic, cellular analysis).
The 2 groups in the trial
- DMEDExisting treatment, for comparison
Dorsal myelotomy and expansive duraplasty (DMED) only.
- DMED + ANGIExisting treatment, for comparison
Dorsal myelotomy and expansive duraplasty (DMED) and supplemental autologous nerve graft implantation (ANGI).
Treatment: DMED and ANGI
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Minimizing Secondary Injury in Patient With SCI Using Expansive Duroplasty
- Plain-language title
- Spinal Surgery With or Without Nerve Graft After Sudden Spinal Cord InjuryGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Criteria questions
- Built from NCT06243211, who can take part
- Publications
- Record updated
- 10 December 2025